In the coming weeks, we'll be publishing the latest edition of the “Proteomics and neuroscience” eBook! This update will focus on how researchers are already using the Nautilus Voyager™ Platform to reveal hidden neurobiology. Read our latest blog post for a sneak peek and to learn how you can sign up to receive your copy as soon as it's available. https://lnkd.in/grhjFJx6
Nautilus Biotechnology
Biotechnology Research
San Carlos, California 13,558 followers
Delivering on the Promise of the Human Proteome
About us
Born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, Nautilus (Nasdaq: NAUT) set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality. The extraordinary team at Nautilus represents a wide spectrum of disciplines and expertise, including: protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. Nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed.
- Website
-
http://www.nautilus.bio
External link for Nautilus Biotechnology
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- San Carlos, California
- Type
- Public Company
- Founded
- 2016
Locations
-
Primary
Get directions
San Carlos, California, US
-
Get directions
Seattle, Washington, US
Employees at Nautilus Biotechnology
Updates
-
We're excited to attend the 2026 ASMS Conference (May 31- June 4). Nautilus representatives will be at the event to discuss how you can integrate single-molecule proteomics into your workflows. At this year's conference, we're particularly excited to invite you to join the Iterative Mapping Early Access Program. By participating in the program, you'll gain exclusive access to the Nautilus Voyager™ Platform and will be one of the first to use the platform for targeted proteoform analyses and broadscale proteomics. If you'd like to discuss a project or have questions about the Nautilus Voyager™ Platform, please set up a meeting with us at the conference through the link below. https://lnkd.in/gQXJbTNw Nautilus attendees will include 🔵 Andreas Huhmer 🔵 Amber (Kessinger) Faust 🔵 Megan Showalter, PhD 🔵 Jamie Rose Kuhar, Ph.D.
-
-
If you're at Tau Global 2026, keep an eye out for these folks to discover how you can measure tau proteoforms with single-molecule accuracy, sensitivity, and reproducibility on the Nautilus Voyager™ Platform. And if you're not at the conference, be sure to visit our website to learn how you can join the Iterative Mapping Early Access Program and be one of the first to achieve single-molecule clarity in your explorations of biological function. https://lnkd.in/gkVf255y Pictured below from left to right: Amber (Kessinger) Faust, Sheri Wilcox, Andreas Huhmer, Jamie Rose Kuhar, Ph.D.
-
-
The Tau Global Conference starts tomorrow in Washington DC! Keep an eye out for Sheri Wilcox, Andreas Huhmer, Amber (Kessinger) Faust, and Jamie Rose Kuhar, Ph.D. throughout the conference and be sure to drop by the following posters to explore Novel tau proteoform data generated on the Nautilus Voyager™ Platform: 📊 Iterative Mapping of Tau Proteoforms Uncovers Regional Heterogeneity in Alzheimer's Disease (P-47) 🗓️ Thursday, May 14th, from 8:30am -4pm 🗣️ Andreas Huhmer Ph.D., Senior Director of Scientific Affairs and Alliance Management, Nautilus Biotechnology 📊 IVS10+16 MAPT Mutation: Phenotyping in Cortical and Midbrain Organoids (P-31) 🗓️ Friday, May 15th, from 8:30am-4pm 🗣️ Taylor Bertucci Ph.D., Principal Investigator, Regenerative Research Foundation/Neural Stem Cell Institute
-
-
We hope to see you at Tau Global 2026 in Washington D.C. this Thursday and Friday (May 14 and 15th). If you'd like to learn how you can use Iterative Mapping and the Nautilus Voyager™ Platform to quantify up to 768 tau proteoforms in your samples of interest, be sure to drop by our poster (#47) or set up a meeting with a Nautilus representative by clicking the link below: https://lnkd.in/dREDv95f
-
-
Nautilus VP of Scientific Engagement, Sheri Wilcox Ph.D., will be presenting at Georgetown University on Wednesday May 13th. If you're in town, drop by to discover how you can achieve single-molecule insights with Iterative Mapping on the Nautilus Voyager™ Platform. And to find all of our upcoming events, be sure to visit our events page: https://lnkd.in/gba_hunU
-
-
We're excited to attend the 2026 Tau Global Conference (May 14-15). Nautilus representatives will be at the event to discuss how you can integrate single-molecule proteomics into your workflows. At this year's conference, we're particularly excited to invite you to join our Iterative Mapping Early Access Program. By participating in the program, you'll gain exclusive access to the Nautilus Tau Proteoforms Assay enabling the quantification of up to 768 tau proteoforms! If you'd like to discuss a project or have questions about the Nautilus Voyager™ Platform, please set up a meeting with us at the conference through the link below. We'll also have a poster at the event and will share poster details soon! https://lnkd.in/dREDv95f
-
-
🗓️ We're expanding our presence at conferences, roadshows, and more as we recruit innovative scientists like you to incorporate the Nautilus Voyager™ Platform into their workflows and join the Iterative Mapping Early Access Program. To see where we'll be in the coming months, check out our Events Page: https://lnkd.in/gba_hunU ✍ And if you'd like to set up an event at your organization, fill out the form at the bottom of the page, and we'll be in touch. We hope to see you soon!
-
-
This Thursday April 23rd at 11:40am PT, Nautilus Co-Founder and CEO Sujal Patel will be speaking on a panel at the Biocom #ConvergeSummit about the role AI tools are playing in the biotech industry. The panel will include: Jacob Berlin, PhD - Co-Founder & CEO of Terray Therapeutics Kexin Huang, PhD - Co-Founder & CEO of Phylo Michelle Lee - Founder & CEO of Medra Amir M. - Director of Business Development at Therna Biosciences Dylan Reid - Managing Director at Zetta Venture Partners We look forward to a fascinating discussion! https://lnkd.in/g_CEyMMt
-
-
In our latest blog post, we cover some of the highlights from a recent episode of the Translating Proteomics podcast featuring Professor Olga Vitek from Northeastern University. Read the post to discover how statistics and AI can help us achieve a more holistic understanding of biology and listen to the podcast episode for even more insights. https://lnkd.in/gynzEfsn #TranslatingProteomics #Podcast #Proteomics #Statistics #AI #ArtificialIntelligence
-